1. Home
  2. THRM vs REPL Comparison

THRM vs REPL Comparison

Compare THRM & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$29.31

Market Cap

844.7M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$6.22

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
REPL
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
844.7M
692.8M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
THRM
REPL
Price
$29.31
$6.22
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$39.40
$11.13
AVG Volume (30 Days)
194.0K
2.3M
Earning Date
04-23-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.25
EPS
0.59
N/A
Revenue
$554,979,000.00
N/A
Revenue This Year
$4.90
N/A
Revenue Next Year
$7.19
N/A
P/E Ratio
$49.77
N/A
Revenue Growth
50.16
N/A
52 Week Low
$22.90
$2.68
52 Week High
$39.48
$13.24

Technical Indicators

Market Signals
Indicator
THRM
REPL
Relative Strength Index (RSI) 51.67 29.54
Support Level $27.02 $4.39
Resistance Level $29.37 $4.95
Average True Range (ATR) 0.88 0.83
MACD 0.33 -0.23
Stochastic Oscillator 84.96 0.00

Price Performance

Historical Comparison
THRM
REPL

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: